Datasheet | February 12, 2012

Early Phase Development Datasheet

Source: ICON

ICON Development Solutions specializes in the strategy and delivery of early phase clinical development for informed, timely decision making. With expertise in early phase clinical research, bioanalytical, PK/PD modelling & simulation and the full range of supporting services, we incorporate scientific excellence and product development strategy in all that we do. Our multi-disciplinary experts have the experience to address the most demanding drug development challenges with an unyielding focus on completing clinical studies on time, on budget and with the quality that will withstand the most vigorous scrutiny.

The clinical pharmacology team at ICON Development Solutions (ICON) has extensive experience in the design, study conduct and interpretation of clinical pharmacology studies across all major therapeutic areas. In particular, ICON has a strong reputation in high science approaches to clinical development, including a full suite of pharmacodynamic markers. ICON applies this scientific and operational excellence across all elements of your clinical pharmacology program.